Enliven Therapeutics, Inc. (ELVN) Corporate Subsidiaries
Enliven Therapeutics, Inc. (ELVN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ELVN
CIK: 1672619
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerAndrew Trivella
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-16 | 2026-10-14 | 4 Filing | 0001266163-26-000003 | View SEC Doc Filr Page |
| 3 | 2026-10-16 | 2026-10-14 | 3 Filing | 0001266163-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-10-14 | 2026-10-14 | 8-K | 0001193125-26-421761 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-01 | 4 Filing | 0001533228-26-000009 | View SEC Doc Filr Page |
| 144 | 2026-10-01 | — | 144 Filing | 0001950047-26-009907 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-17 | 4 Filing | 0001882764-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-17 | 4 Filing | 0001701247-26-000013 | View SEC Doc Filr Page |
| 144 | 2026-09-17 | — | 144 Filing | 0001974158-26-000103 | View SEC Doc Filr Page |
| 144 | 2026-09-04 | — | 144 Filing | 0001959173-26-006749 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | 4 Filing | 0001882764-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | 4 Filing | 0001701247-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-08-06 | 2026-08-04 | 4 Filing | 0001865125-26-000004 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-001988 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001193125-26-335155 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001193125-26-335101 | View SEC Doc Filr Page |
| 144 | 2026-08-04 | — | 144 Filing | 0001974158-26-000095 | View SEC Doc Filr Page |
| 4 | 2026-07-21 | 2026-07-17 | 4 Filing | 0001882764-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-07-21 | 2026-07-17 | 4 Filing | 0001701247-26-000011 | View SEC Doc Filr Page |
| 144 | 2026-07-17 | — | 144 Filing | 0001974158-26-000084 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-06 | 4 Filing | 0001536368-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-22 | 4 Filing | 0000947871-26-000653 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-24 | — | SCHEDULE 13D/A Filing | 0000947871-26-000651 | View SEC Doc Filr Page |
| 144 | 2026-06-22 | — | 144 Filing | 0000947871-26-000650 | View SEC Doc Filr Page |
| 144 | 2026-06-22 | — | 144 Filing | 0000947871-26-000649 | View SEC Doc Filr Page |
| 144 | 2026-06-22 | — | 144 Filing | 0000947871-26-000648 | View SEC Doc Filr Page |